CD8A and myasthenia gravis: Moreover, it is proposed as a modulator of both CD4+ and CD8+ T cells survival and is strongly expressed in B cells in the thymus and particularly in those surrounding germinal centers [24], possibly sustaining an ongoing immune response in MG.